Ars Pharmaceuticals Inc. (SPRY)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Deerfield Management

James E. Flynn

11,077,927 $94,273,159 1.56%
2.
RA Capital Management

Peter Kolchinsky

10,860,977 $92,426,914 1.22%
3.
OrbiMed Advisors

Samuel Isaly

9,240,887 $78,639,948 1.55%
4.
Perceptive Advisors

Joseph Edelman

867,319 $7,380,885 0.17%
5. 645,700 $5,494,907 +16% 0.05%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.79 505,954 9,958,073 2024-03-27 Filing
$9.55 457,745 9,452,119 2024-03-26 Filing
$9.06 437,600 8,994,374 2024-03-25 Filing
$3.78 46,258 Officer 89,227 2023-09-29 Filing
$3.62 40,000 Officer 42,969 2023-09-28 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$11.50 50,000 1,448,499 2024-09-10 Filing
$11.50 50,000 1,396,494 2024-09-10 Filing
$11.50 50,000 1,448,499 2024-09-10 Filing
$11.50 50,000 1,396,494 2024-09-10 Filing
$13.00 83,695 Director 0 2024-08-26 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 4,098,497 $22,459,764 0.01%
2. 4,012,903 $21,990,708 9.23%
3. 3,996,071 $21,898,469 2.15%
4. 3,054,333 $16,737,745 2.13%
5. 2,637,549 $14,453,768 0%
News See All